Seeing Is Believing
Currently out of the existing stock ratings of Brian Tanquilut, 167 are a BUY (73.89%), 53 are a HOLD (23.45%), 6 are a SELL (2.65%).
Analyst Brian Tanquilut, currently employed at JEFFERIES, carries an average stock price target met ratio of 61.71% that have a potential upside of 20.54% achieved within 281 days.
Brian Tanquilut’s has documented 454 price targets and ratings displayed on 37 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CVS, CVS Health Corp at 29-Jun-2025.
Analyst best performing recommendations are on AHCO (ADAPTHEALTH CORP).
The best stock recommendation documented was for MD (MEDNAX) at 11/11/2013. The price target of $62.5 was fulfilled within 39 days with a profit of $46.37 (42.59%) receiving and performance score of 10.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$215
$40.04 (22.89%)
$187
1 years 11 months 10 days ago
(06-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
1 years 11 months 14 days ago
(02-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
1 years 11 months 14 days ago
(02-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
1 years 11 months 14 days ago
(02-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
1 years 11 months 16 days ago
(31-Jul-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Brian Tanquilut is most bullish on?
Which stock is Brian Tanquilut is most reserved on?
What Year was the first public recommendation made by Brian Tanquilut?